Every year, thousands of people lose their lives to hereditary diseases, such as breast cancer, because of the high cost of genomic diagnosis or the slow speed of such analysis. Furthermore, many countries even lack the facilities to carry out genomic diagnosis at all.
Newgenia and Digital Dividend is working to solve this problem and create a solution that will enable faster, safer and cheaper genomic data analysis for everyone who needs it. Digital Dividend supports through staff and capital.
Read more here: www.newgenia.com